Apr 25, 2023 New COVID-19 Healthcare Fraud Enforcement Action from DOJ Highlights Pandemic-Related Risks By Christopher Tonellato Meera Patel Background The Department of Justice announced the largest scale coordinated law enforcement action targeting COVID-19 healthcare fraud...
Mar 16, 2023 Insights for Healthcare Organizations: DOJ's March 2023 Updates to Evaluation of Corporate Compliance Programs Guidance By Christopher Tonellato The U.S. Department of Justice (DOJ) has made another update to its Evaluation of Corporate Compliance Programs (ECCP) guidance announced...
Mar 01, 2023 The Department of Justice’s Withdrawal of Three Antitrust Statements and the Impact on Health Care Organizations By Christopher Tonellato Lindsey Silva On February 3, 2023, the Department of Justice Antitrust Division (DOJ) announced the withdrawal of three policy statements that have...
Dec 21, 2022 Key Compliance Takeaways from DOJ Memorandum By Christopher Tonellato “Further Revisions to Corporate Criminal Enforcement Policies Following Discussions with Corporate Crime Advisory Group”Compliance...
Sep 13, 2022 Risk Assessments: Why, What, When, How By Christopher Tonellato As featured in Compliance Today, September 2022A compliance program can only be truly effective at accomplishing its goal of preventing...
Dec 02, 2021 Don’t Let the No Surprises Act Surprise You By Christopher Tonellato The No Surprises Act and related regulations will come into enforcement January 1, 2022. Many of the new requirements and restrictions...